Olprinone Hydrochloride Hydrate

盐酸奥普力农

Report date: 2022/05/12 17:20:36
NME

Base Information

Drug NameOlprinone Hydrochloride Hydrate
Drug Alias NameOlprinonum奥普力农盐酸盐奥普力农CoretecE--1020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaHeart Failure
Original Approved Country/TerritoryJapan
Original Approved Date1996/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co LtdHebei Aier Haitai Pharmaceutical Co Ltd
Inactive CompaniesBeijing Furuikangzheng Medicine Technology Research Institute
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC01CE
Related LinksWikipediaKEGG